Dr. Martens plc (LON:DOCS – Get Free Report)’s stock price shot up 14.9% during mid-day trading on Thursday after the company announced a dividend. The stock traded as high as GBX 70 ($0.89) and last traded at GBX 66.40 ($0.84). 9,112,005 shares changed hands during trading, an increase of 328% from the average session volume of 2,131,099 shares. The stock had previously closed at GBX 57.80 ($0.73).
The newly announced dividend which will be paid on Tuesday, April 8th. Investors of record on Thursday, March 6th will be issued a GBX 0.85 ($0.01) dividend. This represents a yield of 1.47%. The ex-dividend date is Thursday, March 6th. Dr. Martens’s dividend payout ratio is 4,285.71%.
Dr. Martens Stock Up 13.6 %
The company has a debt-to-equity ratio of 129.55, a quick ratio of 1.13 and a current ratio of 2.85. The company’s 50-day moving average price is GBX 55.88 and its 200 day moving average price is GBX 68.38. The stock has a market capitalization of £631.37 million, a P/E ratio of 932.47, a P/E/G ratio of 6.40 and a beta of 0.11.
Insider Buying and Selling
About Dr. Martens
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
Further Reading
- Five stocks we like better than Dr. Martens
- What is Insider Trading? What You Can Learn from Insider Trading
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- 3 REITs to Buy and Hold for the Long Term
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What is the Australian Securities Exchange (ASX)
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.